ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects and Related Topics by Macaulay Onuigbo.

Image of Macaulay Amechi, M.D. Onuigbo

Dr Onuigbo is the author of a new reference book in 2 volumes: ACE
Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects and
Related Topics.

Most importantly, there is a major Nigerian imprint in this product with several chapters contributed by Nigerian specialist physicians both at home (University of Ilorin Teaching Hospital, Obafemi Awolowo University/Teaching Hospitals Complex, Ile-Ife, Nnamdi Azikiwe Teaching Hospital, Nnewi, University of Nigeria Teaching Hospital, Ituku Ozalla, Enugu, and Federal Teaching Hospital Abakaliki) and in the diaspora (USA and The Caribbean).

Dr. Onuigbo is an Associate Professor of Medicine, College of Medicine, Mayo Clinic, Rochester, US and Nephrologist/Hypertension Specialist, Mayo Clinic Health System, Eau Claire, WI, USA. He is board certified in Internal Medicine and Nephrology, a Fellow of the American Society of Nephrology, a Mayo Clinic MacMillan Scholar (2009-2011), a Mayo SOAR Research Grant Recipient, and has over 100 publications including several book chapters and books. He has introduced several new concepts into the modern nephrology literature including the syndrome of late onset renal failure from angiotensin blockade (LORFFAB; 2005) and the syndrome of rapid onset end-stage renal disease (SORO-ESRD; 2010). Dr. Onuigbo has just edited a major reference textbook on ACE Inhibitors in December 2013 with 36 chapters, in two volumes, drawing top world experts as contributors from the USA, South America, Europe including the United Kingdom, Asia including New Zealand, and Africa. Dr. Onuigbo completed an MBA with Healthcare Emphasis in June 2012 and has completed recent works related to healthcare economics, cost-reduction paradigms in healthcare both in ESRD hemodialysis care and other related healthcare fields.